1. Home
  2. ELUT vs PETS Comparison

ELUT vs PETS Comparison

Compare ELUT & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • PETS
  • Stock Information
  • Founded
  • ELUT 2015
  • PETS 1996
  • Country
  • ELUT United States
  • PETS United States
  • Employees
  • ELUT 54
  • PETS N/A
  • Industry
  • ELUT Medical Specialities
  • PETS Retail-Drug Stores and Proprietary Stores
  • Sector
  • ELUT Health Care
  • PETS Consumer Staples
  • Exchange
  • ELUT Nasdaq
  • PETS Nasdaq
  • Market Cap
  • ELUT 145.2M
  • PETS 118.8M
  • IPO Year
  • ELUT 2020
  • PETS N/A
  • Fundamental
  • Price
  • ELUT $4.20
  • PETS $5.58
  • Analyst Decision
  • ELUT Strong Buy
  • PETS Sell
  • Analyst Count
  • ELUT 2
  • PETS 2
  • Target Price
  • ELUT $10.00
  • PETS $3.50
  • AVG Volume (30 Days)
  • ELUT 42.1K
  • PETS 296.2K
  • Earning Date
  • ELUT 11-14-2024
  • PETS 02-06-2025
  • Dividend Yield
  • ELUT N/A
  • PETS N/A
  • EPS Growth
  • ELUT N/A
  • PETS N/A
  • EPS
  • ELUT N/A
  • PETS N/A
  • Revenue
  • ELUT $24,782,000.00
  • PETS $259,343,000.00
  • Revenue This Year
  • ELUT $8.00
  • PETS N/A
  • Revenue Next Year
  • ELUT $39.89
  • PETS $3.36
  • P/E Ratio
  • ELUT N/A
  • PETS N/A
  • Revenue Growth
  • ELUT N/A
  • PETS N/A
  • 52 Week Low
  • ELUT $1.86
  • PETS $2.90
  • 52 Week High
  • ELUT $5.24
  • PETS $7.79
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 52.78
  • PETS 56.24
  • Support Level
  • ELUT $3.90
  • PETS $5.41
  • Resistance Level
  • ELUT $4.40
  • PETS $6.85
  • Average True Range (ATR)
  • ELUT 0.39
  • PETS 0.45
  • MACD
  • ELUT -0.04
  • PETS -0.01
  • Stochastic Oscillator
  • ELUT 24.59
  • PETS 48.37

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.

Share on Social Networks: